Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

VANCOUVER, British Columbia -- Lobe Sciences, Ltd ("Lobe Sciences" or the "Company") (CSE: LOBE), (OTCQB: LOBEF), a biopharmaceutical company focused on developing products to treat diseases with unmet medical needs, today announced that is has formed a wholly owned U.S. subsidiary named Alera Pharma, Inc. (Alera). Alera will be assigned the intellectual property rights focused on the Company’s neurological assets and its new chemical entity Psilocin Mucate. Read More

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.

Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.